Posts Tagged ‘Personalized Medicine World Congress’
The State of Personalized Medicine: The Role of Biomarkers
(Editor’s Note: this is Part 1 of the new 3‑part series written by Dr. Evian Gordon drawing from his participation at the Personalized Medicine World Congress on January, 23, 2012 at Stanford University.) On average, the medications prescribed for brain-related conditions benefit approximately 50% of patients. But which 50%? Personalized Medicine seeks to move away from…
Read MoreNew Series on Personalized Medicine and the Brain (PMWC 2012)
“On average, the medications prescribed for brain-related conditions benefit approximately 50% of patients. But which 50%?.” “We need unambiguous biomarkers that are clinically relevant and scalable at reasonable cost. They already exist in Cancer. But they do not yet exist in the Brain.” What may change that?
Read More